BACKGROUND: Previous studies have suggested that asymptomatic carriers of toxigenic Clostridium difficile are a source of hospital-associated (HA) infections. Multilocus variable number of tandem repeats analysis (MLVA) is a highly discriminatory molecular subtyping tool that helps to determine possible transmission sources. METHODS: Clostridium difficile isolates were recovered from perirectal swabs collected for vancomycin-resistant Enterococcus (VRE) surveillance as well as from clinical C. difficile toxin-positive stool samples from July to November 2009 at the University of Pittsburgh Medical Center Presbyterian (UPMC). MLVA was performed to determine the genetic relationships between isolates from asymptomatic carriers and patients with HA C. difficile infection (HA-CDI). Asymptomatic carriage and HA-CDI isolates were considered to be associated if the carriage isolate was collected before the HA-CDI isolate and if the MLVA genotypes had a summed tandem-repeat difference of ≤ 2. RESULTS: Of 3006 patients screened, 314 (10.4%) were positive for toxigenic C. difficile, of whom 226 (7.5%) were detected only by VRE surveillance cultures. Of 56 incident cases of CDI classified as HA at UPMC during the study with available isolates, 17 (30%) cases were associated with CDI patients, whereas 16 (29%) cases were associated with carriers. Transmission events from prior bed occupants with CDI (n = 2) or carriers (n = 2) were identified in 4 of 56 cases. CONCLUSIONS: In our hospital with an established infection control program designed to contain transmission from symptomatic CDI patients, asymptomatic carriers appear to have played an important role in transmission. Identification and isolation of carriers may be necessary to further reduce transmission of C. difficile in such settings.
BACKGROUND: Previous studies have suggested that asymptomatic carriers of toxigenic Clostridium difficile are a source of hospital-associated (HA) infections. Multilocus variable number of tandem repeats analysis (MLVA) is a highly discriminatory molecular subtyping tool that helps to determine possible transmission sources. METHODS:Clostridium difficile isolates were recovered from perirectal swabs collected for vancomycin-resistant Enterococcus (VRE) surveillance as well as from clinical C. difficile toxin-positive stool samples from July to November 2009 at the University of Pittsburgh Medical Center Presbyterian (UPMC). MLVA was performed to determine the genetic relationships between isolates from asymptomatic carriers and patients with HA C. difficileinfection (HA-CDI). Asymptomatic carriage and HA-CDI isolates were considered to be associated if the carriage isolate was collected before the HA-CDI isolate and if the MLVA genotypes had a summed tandem-repeat difference of ≤ 2. RESULTS: Of 3006 patients screened, 314 (10.4%) were positive for toxigenic C. difficile, of whom 226 (7.5%) were detected only by VRE surveillance cultures. Of 56 incident cases of CDI classified as HA at UPMC during the study with available isolates, 17 (30%) cases were associated with CDI patients, whereas 16 (29%) cases were associated with carriers. Transmission events from prior bed occupants with CDI (n = 2) or carriers (n = 2) were identified in 4 of 56 cases. CONCLUSIONS: In our hospital with an established infection control program designed to contain transmission from symptomatic CDI patients, asymptomatic carriers appear to have played an important role in transmission. Identification and isolation of carriers may be necessary to further reduce transmission of C. difficile in such settings.
Authors: Scott R Curry; Jane W Marsh; Carlene A Muto; Mary M O'Leary; A William Pasculle; Lee H Harrison Journal: J Clin Microbiol Date: 2006-10-11 Impact factor: 5.948
Authors: L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty Journal: Infect Control Hosp Epidemiol Date: 2007-01-25 Impact factor: 3.254
Authors: Trevor D Lawley; Simon Clare; Laura J Deakin; David Goulding; Jennifer L Yen; Claire Raisen; Cordelia Brandt; Jon Lovell; Fiona Cooke; Taane G Clark; Gordon Dougan Journal: Appl Environ Microbiol Date: 2010-08-27 Impact factor: 4.792
Authors: Michelle M Riggs; Ajay K Sethi; Trina F Zabarsky; Elizabeth C Eckstein; Robin L P Jump; Curtis J Donskey Journal: Clin Infect Dis Date: 2007-09-04 Impact factor: 9.079
Authors: Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; Susan P Sambol; Stuart Johnson; Dale N Gerding; Lee H Harrison Journal: J Clin Microbiol Date: 2009-12-02 Impact factor: 5.948
Authors: Ari Robicsek; Jennifer L Beaumont; Suzanne M Paule; Donna M Hacek; Richard B Thomson; Karen L Kaul; Peggy King; Lance R Peterson Journal: Ann Intern Med Date: 2008-03-18 Impact factor: 25.391
Authors: Carlene A Muto; Mary Kathleen Blank; Jane W Marsh; Emanuel N Vergis; Mary M O'Leary; Kathleen A Shutt; Anthony W Pasculle; Marian Pokrywka; Juliet G Garcia; Kathy Posey; Terri L Roberts; Brian A Potoski; Gary E Blank; Richard L Simmons; Peter Veldkamp; Lee H Harrison; David L Paterson Journal: Clin Infect Dis Date: 2007-10-09 Impact factor: 9.079
Authors: A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; Rosalind M Harding; Lily O'Connor; David Griffiths; Ali Vaughan; John Finney; Mark H Wilcox; Derrick W Crook; Tim E A Peto Journal: PLoS Med Date: 2012-02-07 Impact factor: 11.069
Authors: Brittany C Eckstein; Daniel A Adams; Elizabeth C Eckstein; Agam Rao; Ajay K Sethi; Gopala K Yadavalli; Curtis J Donskey Journal: BMC Infect Dis Date: 2007-06-21 Impact factor: 3.090
Authors: Alison L Galdys; Jemma S Nelson; Kathleen A Shutt; Jessica L Schlackman; Diana L Pakstis; A William Pasculle; Jane W Marsh; Lee H Harrison; Scott R Curry Journal: J Clin Microbiol Date: 2014-04-23 Impact factor: 5.948
Authors: Mini Kamboj; Anna Sheahan; Janet Sun; Ying Taur; Elizabeth Robilotti; Esther Babady; Genovefa Papanicolaou; Ann Jakubowski; Eric Pamer; Kent Sepkowitz Journal: Infect Control Hosp Epidemiol Date: 2015-10-21 Impact factor: 3.254